Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia

STZ-treated animals exhibit cognitive deficits and histopathological changes seen in dementia. This model of dementia warrants continued investigation to better understand the role that DM plays in dementia-related alterations.